DVA vs SER · P/E 14, rev $12.82B vs rev $56.0K
DaVita HealthCare Partners Inc (DVA) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. SER currently screens at market cap $29.7M.
Not investment advice. Open the DVA and SER stock pages for the full models.
Not investment advice.